Mannkind (MNKD) Cash & Equivalents (2010 - 2026)
Mannkind (MNKD) reported Cash & Equivalents of $53.6 million for Q1 2026, up 11.51% year-over-year from $48.1 million in Q1 2025, and down 28.45% on a QoQ basis from $74.9 million in Q4 2025.
Mannkind (MNKD) has 17 years of Cash & Equivalents data on file, last reported at $53.6 million in Q1 2026.
- Quarterly Cash & Equivalents rose 11.51% year-over-year to $53.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.6 million (up 11.51% YoY) and the FY2025 annual result came in at $74.9 million, up 59.07% from the prior year.
- Cash & Equivalents retreated to $53.6 million in Q1 2026 per MNKD's latest filing, from $74.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $238.5 million in Q4 2023 and bottomed at $35.5 million in Q2 2022.
- The 5-year median for Cash & Equivalents is $69.8 million (2022), against an average of $87.2 million.
- The widest annual swing landed in 2023, when Cash & Equivalents surged 241.82%; it then tumbled 80.26% in 2024.
- Tracing MNKD's Cash & Equivalents over 5 years: stood at $69.8 million in 2022, then surged by 241.82% to $238.5 million in 2023, then plunged by 80.26% to $47.1 million in 2024, then soared by 59.07% to $74.9 million in 2025, then retreated by 28.45% to $53.6 million in 2026.
- Per Business Quant, the three latest MNKD Cash & Equivalents figures stand at $53.6 million (Q1 2026), $74.9 million (Q4 2025), and $127.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 53.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.58 Mn |
| Dec 31, 2025 | 74.88 Mn |
| Sep 30, 2025 | 127.39 Mn |
| Jun 30, 2025 | 57.01 Mn |
| Mar 31, 2025 | 48.05 Mn |
| Dec 31, 2024 | 47.08 Mn |
| Sep 30, 2024 | 63.11 Mn |
| Jun 30, 2024 | 97.38 Mn |
| Mar 31, 2024 | 193.27 Mn |
| Dec 31, 2023 | 238.48 Mn |
| Sep 30, 2023 | 83.02 Mn |
| Jun 30, 2023 | 86.18 Mn |
| Mar 31, 2023 | 85.87 Mn |
| Dec 31, 2022 | 69.77 Mn |
| Sep 30, 2022 | 54.31 Mn |
| Jun 30, 2022 | 35.50 Mn |
| Mar 31, 2022 | 67.20 Mn |
| Dec 31, 2021 | 124.18 Mn |
| Sep 30, 2021 | 51.70 Mn |
| Jun 30, 2021 | 62.50 Mn |
| Mar 31, 2021 | 247.83 Mn |
| Dec 31, 2020 | 67.01 Mn |
| Sep 30, 2020 | 52.40 Mn |
| Jun 30, 2020 | 63.22 Mn |
| Mar 31, 2020 | 38.87 Mn |
| Dec 31, 2019 | 29.91 Mn |
| Sep 30, 2019 | 30.17 Mn |
| Jun 30, 2019 | 7.97 Mn |
| Mar 31, 2019 | 34.53 Mn |
| Dec 31, 2018 | 71.16 Mn |
| Sep 30, 2018 | 10.45 Mn |
| Jun 30, 2018 | 26.18 Mn |
| Mar 31, 2018 | 26.71 Mn |
| Dec 31, 2017 | 43.95 Mn |
| Sep 30, 2017 | 10.00 Mn |
| Jun 30, 2017 | 43.38 Mn |
| Mar 31, 2017 | 47.98 Mn |
| Dec 31, 2016 | 22.90 Mn |
| Sep 30, 2016 | 35.53 Mn |
| Jun 30, 2016 | 63.73 Mn |
| Mar 31, 2016 | 27.65 Mn |
| Dec 31, 2015 | 59.07 Mn |
| Sep 30, 2015 | 32.93 Mn |
| Jun 30, 2015 | 107.19 Mn |
| Mar 31, 2015 | 120.84 Mn |
| Dec 31, 2014 | 120.84 Mn |
| Sep 30, 2014 | 172.47 Mn |
| Jun 30, 2014 | 41.21 Mn |
| Mar 31, 2014 | 35.76 Mn |
| Dec 31, 2013 | 70.79 Mn |
| Sep 30, 2013 | 93.80 Mn |
| Jun 30, 2013 | 28.53 Mn |
| Mar 31, 2013 | 28.01 Mn |
| Dec 31, 2012 | 61.84 Mn |
| Sep 30, 2012 | 1.77 Mn |
| Jun 30, 2012 | 31.64 Mn |
| Mar 31, 2012 | 56.36 Mn |
| Dec 31, 2011 | 2.68 Mn |
| Sep 30, 2011 | 22.79 Mn |
| Jun 30, 2011 | 24.77 Mn |
| Mar 31, 2011 | 46.91 Mn |
| Dec 31, 2010 | 66.06 Mn |
| Sep 30, 2010 | 97.93 Mn |
| Jun 30, 2010 | 28.36 Mn |